MedTech Innovator announces the 50 MedTech startups selected for 2021 to participate in the annual Showcase and Accelerator program.
Humana and League have announced a partnership to collaborate on a novel digital health and benefits platform.
AppliedVR, a digital therapeutics company leading the way in developing the next generation of digital medicine, has announced $29 million in Series A funding.
Pack Health and National Multiple Sclerosis Society Announce Partnership to Support Patients with MS
Leading patient engagement platform Pack Health and the National Multiple Sclerosis Society today announced their partnership to optimize and implement a patient-centered digital health coaching program for patients with multiple sclerosis (MS).
Cedar, an innovative patient engagement and financial technology platform, has closed $200M in Series D financing, bringing total funding to more than $350M. We will also highlight two key findings from the recently released 2020 Healthcare Consumer Study commissioned by Cedar and managed by Forrester Consulting.
Digital Therapeutics company Medisafe and Everyday Health announce the launch of the new condition-specific resource centers through the Medisafe platform.
Evidation Health, American College of Cardiology Announce Achievement for Heart Health, A Program to Help Individuals Monitor and Improve Cardiovascular Health
The American College of Cardiology (ACC) and Evidation Health are joining forces to develop Achievement for Heart Health. This first-of-its-kind health engagement experience will deliver evidence-based content, resources, and tools to thousands of individuals experiencing heart failure. This program, built on Evidation’s Achievement platform, will make it easier than ever before for individuals to better understand and engage with their cardiovascular health outside clinic-based settings.
ChristianaCare Adds Prescription Digital Therapeutics for Treatment of Substance Use Disorders | Pear Therapeutics
Delaware-based health system ChristianaCare is expanding its innovative work to transform care through data and technology by adding Pear’s prescription digital therapeutics (PDTs or DTx) to treat substance use disorder and opioid use disorder. ChristianaCare will provide patients access to Boston-based Pear Therapeutics Inc.’s reSET and reSET-O PDTs through Project Recovery, ChristianaCare’s outpatient program for people with substance-use disorders.
LifeScan Partners with Truepill™ to Create New Resources for People with Diabetes and Associated Health Conditions
In partnership with Truepill, LifeScan will add an e-commerce platform to its blood glucose monitoring mobile app, allowing users to buy testing supplies and wellness services from their homes. LifeScan will be Truepill’s first partner in diabetes and chronic condition space. For LifeScan, this is a strategic move to expand its OneTouch brand offerings beyond diabetes testing supplies to innovative digital wellness offerings for diabetes and related health conditions, including weight loss, fitness, and hypertension.